Global drug deal announced
Two global drug companies have plans to “become a leader in specialty pharma” through a transaction valued at $6.8 billion.
Teva Pharmaceutical Industries Ltd. announced on May 2 that it plans...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login
to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information:
FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch